Evidence map›Paper›PMID 30029004›Full record

ArticleMolecular cell2018

HuD Is a Neural Translation Enhancer Acting on mTORC1-Responsive Genes and Counteracted by the Y3 Small Non-coding RNA.

Toma Tebaldi, Paola Zuccotti, Daniele Peroni, Marcel Köhn, Lisa Gasperini, Valentina Potrich, Veronica Bonazza, Tatiana Dudnakova, Annalisa Rossi, Guido Sanguinetti and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Toma TebaldiLaboratory of Translational Genomics, Centre for Integrative Biology, University of Trento, Trento 38123, Italy.
Paola ZuccottiLaboratory of Translational Genomics, Centre for Integrative Biology, University of Trento, Trento 38123, Italy.
Daniele PeroniLaboratory of Translational Genomics, Centre for Integrative Biology, University of Trento, Trento 38123, Italy.
Marcel KöhnInstitute of Molecular Medicine, Martin-Luther-University Halle-Wittenberg, Halle 06120, Germany; Julius-Bernstein-Institute of Physiology, Martin-Luther-University Halle-Wittenberg, Halle 06097, Germany.
Lisa GasperiniLaboratory of Molecular and Cellular Neurobiology, Centre for Integrative Biology, University of Trento, Trento 38123, Italy.
Valentina PotrichLaboratory of Translational Genomics, Centre for Integrative Biology, University of Trento, Trento 38123, Italy.
Veronica BonazzaLaboratory of Translational Genomics, Centre for Integrative Biology, University of Trento, Trento 38123, Italy.
Tatiana DudnakovaWellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, UK.
Annalisa RossiLaboratory of Molecular and Cellular Neurobiology, Centre for Integrative Biology, University of Trento, Trento 38123, Italy.
Guido SanguinettiSchool of Informatics, University of Edinburgh, Edinburgh EH8 9AB, UK.
Luciano ContiLaboratory of Stem Cell Biology, Centre for Integrative Biology, University of Trento, Trento 38123, Italy.
Paolo MacchiLaboratory of Molecular and Cellular Neurobiology, Centre for Integrative Biology, University of Trento, Trento 38123, Italy.
Vito D'AgostinoCentre for Integrative Biology, University of Trento, Trento 38123, Italy.
Gabriella VieroInstitute of Biophysics, CNR Unit at Trento, Trento 38123, Italy.
David TollerveyWellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, UK.
Stefan HüttelmaierInstitute of Molecular Medicine, Martin-Luther-University Halle-Wittenberg, Halle 06120, Germany.
Alessandro QuattroneLaboratory of Translational Genomics, Centre for Integrative Biology, University of Trento, Trento 38123, Italy. Electronic address: alessandro.quattrone@unitn.it.
University of Trento · ITMartin Luther University Halle-Wittenberg · DEWellcome Centre for Cell Biology · GBUniversity of Edinburgh · GB

Funding

Wellcome Trust 109916Wellcome Trust 109916/Z/15/Z
6 · The paper itself

Abstract

The RNA-binding protein HuD promotes neurogenesis and favors recovery from peripheral axon injury. HuD interacts with many mRNAs, altering both stability and translation efficiency. We generated a nucleotide resolution map of the HuD RNA interactome in motor neuron-like cells, identifying HuD target sites in 1,304 mRNAs, almost exclusively in the 3' UTR. HuD binds many mRNAs encoding mTORC1-responsive ribosomal proteins and translation factors. Altered HuD expression correlates with the translation efficiency of these mRNAs and overall protein synthesis, in a mTORC1-independent fashion. The predominant HuD target is the abundant, small non-coding RNA Y3, amounting to 70% of the HuD interaction signal. Y3 functions as a molecular sponge for HuD, dynamically limiting its recruitment to polysomes and its activity as a translation and neuron differentiation enhancer. These findings uncover an alternative route to the mTORC1 pathway for translational control in motor neurons that is tunable by a small non-coding RNA.

Indexed as

3' Untranslated RegionsAnimalsATP Binding Cassette Transporter, Subfamily B, Member 2Cell LineELAV-Like Protein 4HumansMechanistic Target of Rapamycin Complex 1MiceMotor NeuronsNeurogenesisPolyribosomesRNA, Long NoncodingRNA, MessengerRNA, Small Untranslated3' Untranslated RegionsATP Binding Cassette Transporter, Subfamily B, Member 2ELAVL4 protein, humanElavl4 protein, mouseELAV-Like Protein 4Mechanistic Target of Rapamycin Complex 1RNA, Long NoncodingRNA, MessengerRNA, Small UntranslatedTap1 protein, mouseY3 non-coding RNA, humanHuD ELAVL4mTORC1neuron differentiationnon-coding RNANSC-34polysomesRNA binding proteintranslationY3 Rny3Y RNA

Identifiers

PMID30029004
PMCPMC6060611
OpenAlexW2883060238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.